Search tips
Search criteria 


Logo of currcardiorevLink to Publisher's site
Curr Cardiol Rev. 2009 May; 5(2): 119–124.
PMCID: PMC2805814

Titin and Troponin: Central Players in the Frank-Starling Mechanism of the Heart


The basis of the Frank-Starling mechanism of the heart is the intrinsic ability of cardiac muscle to produce greater active force in response to stretch, a phenomenon known as length-dependent activation. A feedback mechanism transmitted from cross-bridge formation to troponin C to enhance Ca2+ binding has long been proposed to account for length-dependent activation. However, recent advances in muscle physiology research technologies have enabled the identification of other factors involved in length-dependent activation. The striated muscle sarcomere contains a third filament system composed of the giant elastic protein titin, which is responsible for most passive stiffness in the physiological sarcomere length range. Recent studies have revealed a significant coupling of active and passive forces in cardiac muscle, where titin-based passive force promotes cross-bridge recruitment, resulting in greater active force production in response to stretch. More currently, the focus has been placed on the troponin-based “on-off” switching of the thin filament state in the regulation of length-dependent activation. In this review, we discuss how myocardial length-dependent activation is coordinately regulated by sarcomere proteins.

Keywords: Calcium, cardiac muscle, connectin.

About a century ago, Otto Frank and Earnest Starling demonstrated a fundamental principle in cardiac physiology that an increase in ventricular volume enhances the systolic performance of the heart (i.e., the Frank-Starling law of the heart; see [1] and references therein). “The Law” is a physiologically important characteristic of the heart, which regulates the cardiac output on a beat-to-beat basis. It is widely recognized that “the Law” is the same as the law of the muscle tissues [2], as both Frank and Starling understood, where active force increases in response to stretch. However, despite a number of studies having been undertaken, the molecular mechanism of length-dependent activation has not been fully understood.

First, we would like to summarize the cellular mechanisms of myocardial contraction and relaxation before discussing length-dependent activation. In cardiac muscle, contraction is regulated by micromolar concentrations of Ca2+ that is released from the inner membrane system [3-5]. Upon stimulation of cardiomyocytes, Ca2+ enters the myocyte via sarcolemmal L-type Ca2+ channels. This Ca2+ induces the release of Ca2+ from the sarcoplasmic reticulum (SR) [i.e., Ca2+-induced Ca2+ release mechanism], resulting in the binding of Ca2+ to troponin C (TnC) and the subsequent formation of cross-bridges [i.e., actomyosin (actin-myosin) interaction]. Unlike in skeletal muscle, cardiac myofilaments are not normally fully activated because the intracellular Ca2+ concentration ([Ca2+]i) is maintained relatively low (~10-6 M) in systole [3]. For relaxation to occur, four transport systems are involved to lower [Ca2+]i: (1) sequestration into the SR by the Ca2+-ATPase pump (i.e., SERCA2a protein), (2) efflux via the sarcolemmal Na+/Ca2+ exchanger, (3) extrusion by the sarcolemmal Ca2+-ATPase pump, and (4) uptake into mitochondria via the Ca2+ uniporter. Myofilament relaxation takes place following dissociation of Ca2+ from TnC.

When stretched under physiologic conditions, mammalian cardiac muscle exhibits a biphasic force response to stretch, in that twitch force increases immediately after stretch, followed by a slow and gradual increase in the force. In a pioneering study, Allen and Kurihara [6] used the Ca2+-sensitive photoprotein aequorin and simultaneously measured [Ca2+]i and twitch force in living cardiac muscle. It was demonstrated that the rapid first phase occurs independently of [Ca2+]i, and the second phase is coupled with a rise of [Ca2+]i (i.e., “slow effect”). It is now recognized that the former is controlled by myofilaments and it is responsible for the beat-to-beat basis modulation of the mechanical response to stretch, predominantly underlying the Frank-Starling mechanism. For the slow effect, the following mechanisms have been proposed. First, Ruknudin et al. [7] reported that stretch-activated channels capable of generating inward currents (including Ca2+) may operate to increase [Ca2+]i. Second, Alvarez et al. [8] provided evidence for stretch-induced activation of the sarcolemmal Na+/H+ exchanger by local autocrine/paracrine systems involving angiotensin II and endothelin-1, resulting in an increase in [Na+]i and a subsequent rise of [Ca2+]i (reviewed in [9]). Third, Petroff et al. [10] demonstrated that stretch induces PtdIns-3-OH kinase-dependent phosphorylation of both Akt and the endothelial isoform of nitric oxide synthase, nitric oxide production and an increase in Ca2+-spark frequency. Therefore, the stretch-induced production of nitric oxide may enhance the release of Ca2+ from the SR. In this article, we will focus on the rapid component of the force response after stretch, and discuss how this is integrated in the supramolecular structure sarcomere.

Another important finding by Allen and Kurihara [6] is that a quick release of muscle length from Lmax (where twitch force reaches the maximum) to ~90% Lmax at various points of isometric twitch contraction causes a transient increase in [Ca2+]i (i.e., extra-Ca2+). Subsequent studies revealed that extra-Ca2+ is in proportion to the magnitude of force reduction [11], and is indeed markedly diminished in the presence of the actomyosin inhibitor 2, 3-butanedione monoxime (BDM) [12]. It is therefore considered that cross-bridge formation (or dissociation) enhances (or reduces) Ca2+-binding to TnC via a feedback mechanism, and both complementarily affect each other during twitch contractions. However, recent studies suggest that this is not the sole mechanism involved in length-dependent activation.

The first direct evidence that myofibrillar contractility is increased with length in cardiac muscle was provided by Hibberd and Jewell [13] in experiments with chemically skinned preparations. They observed that active force increases with sarcomere length at submaximal levels, as well as at maximal levels, resulting in the leftward shift of the force-pCa (= –log [Ca2+]) curve (i.e., increase in “Ca2+ sensitivity of force”). This property has been confirmed by a number of researchers, and is now widely recognized to underlie length-dependent activation in cardiac muscle under physiologic conditions.

A straightforward interpretation that can seemingly account for the findings by Hibberd and Jewell [13] may be that TnC plays a role as a “length sensor” that changes its affinity for Ca2+, depending on the length of the sarcomere. This proposal is based on the observation that the length-dependent shift of the force-pCa curve in skinned cardiac muscle is diminished after exchange of TnC for the isoform taken from fast skeletal muscle that shows less length dependency [14, 15]. Later, however, the group of Moss challenged this proposal providing strong evidence that (1) length-dependent activation in skeletal muscle is unaltered after TnC is exchanged for the cardiac isoform [16], and (2) overexpression of skeletal TnC in cardiomyocytes does not alter the length-dependent activation [17]. Also, the findings that lengthening increases (1) maximal Ca2+-activated force (e.g., [13, 18-20]) and (2) Ca2+-independent, rigor cross-bridge-dependent active force [21, 22] render this proposal further unlikely.

Instead, it has been proposed that the leftward shift of the force-pCa curve results from an increase in the fraction of cross-bridges coupled with structural changes in the sarcomere. It is now widely accepted that the actomyosin interaction is a stochastic process (e.g., [23]). It is therefore considered that the attachment of myosin heads to the thin filament is enhanced as the distance between the thick and thin filament is reduced, as simulated by Ishiwata and colleagues based on a mathematical model [24, 25]. Indeed, osmotic compression reduces the lattice spacing and increases contractile force [18, 26, 27], coupled with enhanced cross-bridge formation [28]. Also, studies with synchrotron X-ray have provided direct evidence that the lattice spacing is reduced in response to stretch within the physiological sarcomere length range (i.e., ~1.8 – ~2.4 μm) in various animal species (e.g., [29, 30]). These findings are consistent with the notion that the lattice spacing plays a pivotal role in length-dependent activation (e.g., [18, 26, 27]).

What triggers lattice spacing reduction in cardiac muscle at the stretched state? Does it occur intrinsically in the sarcomere or with a support from the extracellular component such as the collagen network (as suggested in [19])? Recent studies have revealed that the giant sarcomere protein titin (also known as connectin) is involved in the modulation of the lattice spacing (e.g., [31, 32]). Titin is a muscle-specific elastic protein (3–4 MDa) that spans from the Z-line to the M-line in half-sarcomere ([33]; see also recent reviews [34-39]). Titin develops passive force when stretched by external force, resulting from extension of its spring element in the I-band region of the sarcomere (for recent reviews and original citations; [34-39]). While titin’s A-band portion is composed of relatively simple patterns of immunoglobulin (Ig)-like and fibronectin type 3 (Fn3) repeats, the I-band region has a complex sequence with distinct extensible segments: the tandem Ig segments (tandemly arranged Ig-like domains), the PEVK segment [rich in proline (P), glutamate (E), valine (V) and lysine (K)] and the segment that has a unique amino acid sequence (N2A or N2B). In cardiac muscle, two types of titin exist, i.e., stiff N2B titin (containing the N2B segment) and less stiff N2BA titin (containing both N2B and N2A segments) (Fig. 11). N2BA titin contains an additional middle Ig segment, the N2A segment, and the PEVK segment of variable lengths. Therefore, its passive force is lower than that of N2B titin. The expression level of N2B and N2BA titins varies in a species-specific and location-specific manner, but both isoforms are expressed at similar levels in the ventricle of most mammals, including humans [40, 41].

Fig. (1)
Splice isoform diversity in the extensible regions of N2B and N2BA titin isoforms. Both isoforms have constitutive Ig domains and PEVK residues near the A-band. Red, Ig domain; yellow, PEVK domain; blue, unique sequence. Based on [39].

Two articles published in 2001 have significantly expanded our understanding of length-dependent activation by providing evidence that titin is involved in length-dependent activation. First, Cazorla et al. [42] measured force-pCa curves in skinned rat cardiomyocytes at different levels of passive force, modulated by a pre-history of stretch, and found that the magnitude of the sarcomere length-dependent increases in Ca2+ sensitivity of force varies in response to passive force, rather than to sarcomere length. They also found that interfilament lattice spacing is expanded in response to a decrease in titin-based passive force. Titin binds to actin in and near the Z-line [43, 44]. Therefore, titin runs obliquely (not in parallel to the thin filaments) in the sarcomere, resulting in the production of radial force as well as longitudinal force in the lattice; the former force may pull the thin filament closer to the thick filament (Fig. 22). This likely increases the likelihood of myosin binding to actin. In the myofilament lattice, the electrostatic force (Fes) arising from the negative charge carried by thick and thin filaments tends to separate these filaments. Cazorla et al. [42] calculated the values of Fes at various sarcomere lengths and concluded that titin-based radial force and Fes are of similar magnitude in the cardiac myofilament lattice, at least in relaxing conditions. It is therefore likely that titin develops radial force that is large enough for it to play a role in counteracting Fes. Secondly, Fukuda et al. [19] applied limited trypsin treatment to rat ventricular trabeculae to selectively degrade titin, and found that the slope of the length-force curve became less steep. Since attenuation of the length-dependence was observed under conditions where the lattice spacing (as indexed by muscle width) was not significantly changed, it was concluded that a mechanism operating independent of the lattice spacing modulation was responsible. It has been reported that titin is an integral component of the thick filament, tightly binding to myosin and myosin-binding protein C [45]. Therefore, sarcomere extension by external force may cause mechanical strain of the thick filament via titin’s longitudinal force, allowing myosin to attach to actin. Indeed, Wakabayashi et al. [46] reported that in frog skeletal muscle, sarcomere extension causes an increase in the myosin periodicity, accompanied by a loss of characteristic resting order of myosin heads around the thick filament backbone. Thus, a similar mechanism may operate in cardiac muscle within the physiological sarcomere length, based on the higher level of stiffness compared to skeletal muscle. It is therefore reasonable to consider that titin modulates length-dependent activation and that the mechanism includes titin-based modulation of the lattice spacing and the thick filament structure [30-32, 47].

Fig. (2)
Schematic illustration showing the role of titin in the modulation of interfilament lattice spacing (A) and length-dependent changes in the force-pCa curve (B). At a long length, titin produces passive force (F) in the myofilament lattice. The force is ...

β-Adrenergic stimulation induces activation of protein kinase A (PKA), resulting in the phosphorylation of various proteins in cardiomyocytes, causing marked alteration in systolic and diastolic performances of the heart (see [3]). It has been reported that PKA phosphorylates the N2B sequence of titin (both N2B and N2BA isoforms), resulting in a decrease in passive force, especially in the physiological sarcomere length range [48, 49]. Therefore, it may be possible that length-dependent activation is attenuated by PKA, as pointed out elsewhere [22].

However, the group of de Tombe challenged the lattice spacing hypothesis, providing evidence that the lattice spacing and Ca2+ sensitivity of force are not well correlated [50]. Therefore, factors other than the lattice spacing are likely involved in the regulation of length-dependent activation, obtained at the steady-state. Indeed, length-dependent activation reportedly varies as a function of recruitable (i.e., resting) cross-bridges that have ATP and can, therefore, potentially produce force upon attachment to the thin filament [31, 32]. This notion is supported by the experimental evidence from different groups showing that the length dependency is attenuated at high cooperative activation states with a non-force-generating analogue of myosin subfragment 1 (NEM-S1) [51] or MgADP [18] and it is enhanced at low cooperative activation states with inorganic phosphate or H+ [20]. Therefore, the “on-off” equilibrium of the thin filament state, which is regulated by Tn under physiologic conditions, likely determines the magnitude of length-dependent activation in concert with titin-based regulation.

Tn is a heterotrimer of distinct gene products: i.e., TnC (a Ca2+ receptor), TnI (an inhibitor of actomyosin interaction that tightly binds to either actin or Ca2+-TnC) and TnT (an anchor that binds to tropomyosin, TnI and TnC) (e.g., [52-55]). Two metal binding sites exist in the C-terminal domain of TnC that bind both Mg2+ and Ca2+ with relatively high affinity. However, due to the higher concentration of Mg2+ under physiologic conditions (~1 mM compared with ~0.1 – ~1 μM for Ca2+), these sites are normally occupied by Mg2+, during both diastole and systole. Cardiac (fast skeletal) TnC has one (two) regulatory Ca2+-binding site(s) with relatively low affinity in the N-terminal domain of this molecule. When [Ca2+]i is increased during systole, Ca2+ binds to the regulatory Ca2+-binding site, resulting in the onset of the conformational change of the thin filament. During diastole, the C-terminal domain of TnI tightly binds to actin, and tropomyosin blocks the actomyosin interaction (“off” state). However, when Ca2+ binds to the regulatory Ca2+-binding site of TnC during systole, the C-terminal domain of TnI is dissociated from actin and binds to the N-terminal domain of TnC, due to the enhanced TnC-TnI interaction (“on” state). It is generally considered that the transition from the “off” to “on” state is associated with a movement and rotation of tropomyosin on the thin filament [56, 57]. Previous studies have demonstrated that the “on-off” equilibrium depends on the isoform of Tn subunits (e.g., [54]), as well as on the fraction on the strongly bound cross-bridges, such as the actomyosin-ADP complex [58].

A mouse model expressing slow skeletal TnI (that lacks cardiac-specific PKA phosphorylation sites; ssTnI) in the ventricle has been widely used to investigate the physiological properties of TnI under various conditions (e.g., [59]). Ventricular muscle expressing ssTnI shows greater Ca2+ sensitivity of force than control muscle, due presumably to the acceleration of the transition from the “off” state to the “on” state of the thin filament [59, 60]. By using this mouse model, the group of Solaro [60] demonstrated that there was less length-dependent activation in ventricular muscle expressing ssTnI than in control muscle, associated with an increase in Ca2+ sensitivity of force. Later, by taking advantage of a quasi-complete Tn exchange technique, Terui et al. [61] provided strong evidence that the “on-off” equilibrium of the thin filament state plays an important role in length-dependent activation. The authors demonstrated that replacement of endogenous Tn with exogenously added rabbit fast skeletal Tn (sTn) attenuated the length dependency in skinned porcine ventricular muscle, to a magnitude similar to that observed in rabbit fast skeletal muscle (see also [62] for differing magnitudes of length-dependent activation in cardiac and skeletal muscles). Considering the finding that Ca2+ sensitivity of force is increased in association with enhanced cross-bridge formation upon replacement with rabbit fast skeletal Tn [61], the switching of Tn from the cardiac to fast skeletal isoform likely accelerates the transition from the “off” state to the “on” state of the thin filament (similar to the finding in [60]). It is therefore considered that length-dependent activation is attenuated as a result of a decrease in the fraction of recruitable cross-bridges. Also, Terui et al. [61] demonstrated that an increase in titin-based passive force, induced by manipulating the pre-history of stretch (as in [30]), enhanced length-dependent activation, in both control and sTn-reconstituted cardiac muscles, suggesting that this phenomenon is coupled with both titin-based passive force and “on-off” switching of the thin filament state, with titin-based passive force acting as a trigger in this phenomenon.

In conclusion, myocardial length-dependent activation is the basis for the Frank-Starling mechanism of the heart, which is modulated by sarcomere proteins, rather than via a rise in [Ca2+]i. A simultaneous measurement of [Ca2+]i and twitch force in intact cardiac muscle revealed a tight coupling between Ca2+-binding to TnC and cross-bridge formation, both complimentarily affecting each other. Recent studies with skinned myocardial preparations demonstrated that at the steady-state, length-dependent activation is primarily regulated via “on-off” switching of the thin filament state in concert with titin-based lattice spacing modulation. Therefore, under physiologic conditions, cross-bridges recruited via this mechanism may enhance Ca2+-binding to TnC and consequently recruit more cross-bridges. Future work is warranted to fully elucidate the enigmatic phenomenon of length-dependent activation.


This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from the Japan Science and Technology Agency (CREST) to N.F. Fig. (11) is reproduced with permission of the Physiological Society of Japan.


1. Katz AM. Ernest Henry Starling, his predecessors, and the “Law of the Heart” Circulation. 2002;106:2986–2992. [PubMed]
2. Blix M. Die länge und die spannung des muskels. Skand Arch Physiol. 1892;3:295–318.
3. Bers DM. Excitation-contraction coupling and cardiac contractile force. 2nd. Dordrecht, Netherlands: Kluwer-Academic; 2001.
4. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198–205. [PubMed]
5. Fukuda N, O-Uchi J, Kurihara S. Neuronal NO synthase-derived NO: a novel relaxing factor in myocardium? Circ Res. 2008;102:148–150. [PubMed]
6. Allen DG, Kurihara S. The effects of muscle length on intracellular calcium transients in mammalian cardiac muscle. J Physiol (Lond) 1982;327:79–94. [PubMed]
7. Ruknudin A, Sachs F, Bustamante JO. Stretch-activated ion channels in tissue-cultured chick heart. Am J Physiol Heart Circ Physiol. 1993;264:H960–H972. [PubMed]
8. Alvarez BV, Pérez NG, Ennis IL, Camilión de Hurtado MC, Cingolani HE. Mechanisms underlying the increase in force and Ca2+ transient that follow stretch of cardiac muscle: a possible explanation of the Anrep effect. Circ Res. 1999;85:716–722. [PubMed]
9. Kentish JC. A role for the sarcolemmal Na+/H+ exchanger in the slow force response to myocardial stretch. Circ Res. 1999;85:658–660. [PubMed]
10. Petroff MG, Kim SH, Pepe S, Dessy C, Marbán E, Balligand JL, Sollott SJ. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol. 2001;3:867–873. [PubMed]
11. Kurihara S, Komukai K. Tension-dependent changes of the intracellular Ca2+ transients in ferret ventricular muscles. J Physiol (Lond) 1995;489:617–625. [PubMed]
12. Kurihara S, Saeki Y, Hongo K, Tanaka E, Sudo N. Effects of length change on intracellular Ca2+ transients in ferret ventricular muscle treated with 2, 3-butanedione monoxime (BDM) Jpn J Physiol. 1990;40:915–920. [PubMed]
13. Hibberd MG, Jewell BR. Calcium- and length-dependent force production in rat ventricular muscle. J Physiol (Lond) 1982;329:527–540. [PubMed]
14. Babu A, Sonnenblick E, Gulati J. Molecular basis for the influence of muscle length on myocardial performance. Science. 1988;240:74–76. [PubMed]
15. Gulati J, Sonnenblick E, Babu A. The role of troponin C in the length dependence of Ca2+-sensitive force of mammalian skeletal and cardiac muscles. J Physiol (Lond) 1991;441:305–324. [PubMed]
16. Moss RL, Nwoye LO, Greaser ML. Substitution of cardiac troponin C into rabbit muscle does not alter the length dependence of Ca2+ sensitivity of tension. J Physiol (Lond) 1991;440:273–289. [PubMed]
17. McDonald KS, Field LJ, Parmacek MS, Soonpaa M, Leiden JM, Moss RL. Length dependence of Ca2+ sensitivity of tension in mouse cardiac myocytes expressing skeletal troponin C. J Physiol (Lond) 1995;483:131–139. [PubMed]
18. Fukuda N, Kajiwara H, Ishiwata S, Kurihara S. Effects of MgADP on length dependence of tension generation in skinned rat cardiac muscle. Circ Res. 2000;86:e1–e6. [PubMed]
19. Fukuda N, Sasaki D, Ishiwata S, Kurihara S. Length dependence of tension generation in rat skinned cardiac muscle: role of titin in the Frank-Starling mechanism of the heart. Circulation. 2001a;104:1639–1645. [PubMed]
20. Fukuda N, O-Uchi J, Sasaki D, Kajiwara H, Ishiwata S, Kurihara S. Acidosis or inorganic phosphate enhances the length dependence of tension in rat skinned cardiac muscle. J Physiol (Lond) 2001b;536:153–160. [PubMed]
21. Smith SH, Fuchs F. Effect of ionic strength on length-dependent Ca2+ activation in skinned cardiac muscle. J Mol Cell Cardiol. 1999;31:2115–2125. [PubMed]
22. Kajiwara H, Morimoto S, Fukuda N, Ohtsuki I, Kurihara S. Effect of troponin I phosphorylation by protein kinase A on length-dependence of tension activation in skinned cardiac muscle fibers. Biochem Biophys Res Commun. 2000;272:104–110. [PubMed]
23. Huxley AF. Muscle structure and theories of contraction. Prog Biophys Biophys Chem. 1957;7:255–318. [PubMed]
24. Ishiwata S, Oosawa F. A regulatory mechanism of muscle contraction based on the flexibility change of the thin filaments. J Mechanochem Cell Motil. 1974;3:9–17. [PubMed]
25. Shimamoto Y, Kono F, Suzuki M, Ishiwata S. Nonlinear force-length relationship in the ADP-induced contraction of skeletal myofibrils. Biophys J. 2007;93:4330–4341. [PMC free article] [PubMed]
26. McDonald KS, Moss RL. Osmotic compression of single cardiac myocytes eliminates the reduction in Ca2+ sensitivity of tension at short sarcomere length. Circ Res. 1995;77:199–205. [PubMed]
27. Fuchs F, Wang YP. Sarcomere length versus interfilament spacing as determinants of cardiac myofilament Ca2+ sensitivity and Ca2+ binding. J Mol Cell Cardiol. 1996;28:1375–1383. [PubMed]
28. McDonald KS, Wolff MR, Moss RL. Sarcomere length dependence of the rate of tension redevelopment and submaximal tension in rat and rabbit skinned skeletal muscle fibres. J Physiol (Lond) 1997;50:607–621. [PubMed]
29. Irving TC, Konhilas J, Perry D, Fischetti R, de Tombe PP. Myofilament lattice spacing as a function of sarcomere length in isolated rat myocardium. Am J Physiol Heart Circ Physiol. 2000;279:H2568–H2573. [PubMed]
30. Fukuda N, Wu Y, Farman G, Irving TC, Granzier H. Titin isoform variance and length dependence of activation in skinned bovine cardiac muscle. J Physiol (Lond) 2003;553:147–154. [PubMed]
31. Fukuda N, Granzier H. Role of the giant elastic protein titin in the Frank-Starling mechanism of the heart. Curr Vasc Pharmacol. 2004;2:135–139. [PubMed]
32. Fukuda N, Granzier HL. Titin/connectin-based modulation of the Frank-Starling mechanism of the heart. J Muscle Res Cell Motil. 2005;26:319–323. [PubMed]
33. Labeit S, Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science. 1995;270:293–296. [PubMed]
34. Granzier H, Labeit S. Cardiac titin: an adjustable multi-functional spring. J Physiol (Lond) 2002;541:335–342. [PubMed]
35. Granzier HL, Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ Res. 2004;94:284–295. [PubMed]
36. Granzier H, Wu Y, Labeit S, LeWinter M. Titin: physiological function and role in cardiomyopathy and failure. Heart Fail Rev. 2005;10:211–223. [PubMed]
37. Granzier H, Labeit S. Structure-function relations of the giant elastic protein titin in striated and smooth muscle cells. Muscle Nerve. 2007;36:740–755. [PubMed]
38. Linke WA. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res. 2008;77:637–648. [PubMed]
39. Fukuda N, Granzier HL, Ishiwata S, Kurihara S. Physiological functions of the giant elastic protein titin in mammalian striated muscle. J Physiol Sci. 2008;58:151–159. [PubMed]
40. Cazorla O, Freiburg A, Helmes M, et al. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ Res. 2000;86:59–67. [PubMed]
41. Wu Y, Cazorla O, Labeit D, Labeit S, Granzier H. Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. J Mol Cell Cardiol. 2000;32:2151–2162. [PubMed]
42. Cazorla O, Wu Y, Irving TC, Granzier H. Titin-based modulation of calcium sensitivity of active tension in mouse skinned cardiac myocytes. Circ Res. 2001;88:1028–1035. [PubMed]
43. Funatsu T, Kono E, Higuchi H, et al. Elastic filaments in situ in cardiac muscle: deep-etch replica analysis in combination with selective removal of actin and myosin filaments. J Cell Biol. 1993;120:711–724. [PMC free article] [PubMed]
44. Trombitás K, Granzier H. Actin removal from cardiac myocytes shows that near Z line titin attaches to actin while under tension. Am J Physiol Cell Physiol. 1997;273:C662–C670. [PubMed]
45. Labeit S, Gautel M, Lakey A, Trinick J. Towards a molecular understanding of titin. EMBO J. 1992;11:1711–1716. [PubMed]
46. Wakabayashi K, Sugimoto Y, Tanaka H, Ueno Y, Takezawa Y, Amemiya Y. X-ray diffraction evidence for the estensibility of actin and myosin filaments during muscle contraction. Biophys J. 1994;67:2422–2435. [PubMed]
47. Cazorla O, Vassort G, Garnier D, Le Guennec JY. Length modulation of active force in rat cardiac myocytes: is titin the sensor? J Mol Cell Cardiol. 1999;31:1215–1227. [PubMed]
48. Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H. Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res. 2002;90:1181–1188. [PubMed]
49. Fukuda N, Wu Y, Nair P, Granzier HL. Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol. 2005;125:257–271. [PMC free article] [PubMed]
50. Konhilas JP, Irving TC, de Tombe PP. Myofilament calcium sensitivity in skinned rat cardiac trabeculae: role of interfilament spacing. Circ Res. 2002;90:59–65. [PubMed]
51. Fitzsimons DP, Moss RL. Strong binding of myosin modulates length-dependent Ca2+ activation of rat ventricular myocytes. Circ Res. 1998;83:602–607. [PubMed]
52. Ohtsuki I, Maruyama K, Ebashi S. Regulatory and cytoskeletal proteins of vertebrate skeletal muscle. Adv Protein Chem. 1986;38:1–67. [PubMed]
53. Solaro RJ, Van Eyk J. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol. 1996;28:217–230. [PubMed]
54. Solaro RJ, Rarick HM. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res. 1998;83:471–480. [PubMed]
55. Ohtsuki I, Morimoto S. Troponin: regulatory function and disorders. Biochem Biophys Res Commun. 2008;369:62–73. [PubMed]
56. Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol Rev. 2000;80:853–924. [PubMed]
57. Gordon AM, Regnier M, Homsher E. Skeletal and cardiac muscle contractile activation: tropomyosin "rocks and rolls". News Physiol Sci. 2001;16:49–55. [PubMed]
58. Fukuda N, Fujita H, Fujita T, Ishiwata S. Regulatory roles of MgADP and calcium in tension development of skinned cardiac muscle. J Muscle Res Cell Motil. 1998;19:909–921. [PubMed]
59. Fentzke RC, Buck SH, Patel JR, et al. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol (Lond) 1999;517:143–157. [PubMed]
60. Arteaga GM, Palmiter KA, Leiden JM, Solaro RJ. Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J Physiol (Lond) 2000;526:541–549. [PubMed]
61. Terui T, Sodnomtseren M, Matsuba D, et al. Troponin and titin coordinately regulate length-dependent activation in skinned porcine ventricular muscle. J Gen Physiol. 2008;131:275–283. [PMC free article] [PubMed]
62. Allen DG, Jewell BR, Murray JW. The contribution of activation processes to the length-tension relation of cardiac muscle. Nature. 1974;248:606–607. [PubMed]

Articles from Current Cardiology Reviews are provided here courtesy of Bentham Science Publishers